Combined MWA and immunotherapy amplifies CD8+ T-cell function and memory formation, enriches migratory type 1 dendritic cells, and expands tumor-specific T cells, sustaining immune activity in the TME (50, 51). The gene discussed is CD8A; the disease is neoplasm.